Other Information.
−Removed: Chris Rallis , a current member of our Board of Directors , adopted a trading arrangement on May 19, 2025 , which is intended to satisfy the Rule 10b5-1 affirmative defense.
+Added: Rosty Raykov , a current member of our Board of Directors , adopted a trading arrangement on September 19, 2025 , which is intended to satisfy the Rule 10b5-1 affirmative defense.
This trading arrangement covers the disposition of up to 109,184 shares of the Company’s common shares, and will terminate on June 9, 2026 , unless earlier terminated in accordance with its terms.
No additional directors or officers informed us of the adoption, modification or termination of a “ Rule 10b5-1 trading arrangement” or “non- Rule 10b5-1 trading arrangement ,” as those terms are defined in Regulation S-K, Item 408.
−Removed: On August 14, 2025, we issued a press release announcing our financial results for the quarter ended June 30, 2025.
+Added: On November 13, 2025, we issued a press release announcing our financial results for the quarter ended September 30, 2025.
A copy of the news release is attached to this Quarterly Report as Exhibit 99.1.
3 unchanged sentences
Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Press Release for Quarter June 30, 2025 (filed herewith).
+Added: Press Release for Quarter September 30, 2025 (filed herewith).
Inline XBRL Instance Document
8 unchanged sentences
Fennec Pharmaceuticals Inc.
−Removed: August 14, 2025
+Added: November 13, 2025
/s/ Jeff Hackman
1 unchanged sentence
(principal executive officer)
−Removed: August 14, 2025
+Added: November 13, 2025
/s/ Robert Andrade
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.